Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6559128
Inhibitors of G protein-mediated signaling, methods of making them, and uses thereof
expired -
US 6559167
Prodrugs of proton pump inhibitors
expired -
US 6555565
Apoptosis inhibitor
expired -
US 6548521
Inhibitors of metazoan parasite proteases
expired -
US 6544750
Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
expired -
US 6541496
Inhibitors of IMPDH enzyme
expired -
US 6531506
Inhibitors of epoxide hydrolases for the treatment of hypertension
expired -
US 6531474
Inhibitors of caspases
expired -
US 6528509
Pyrazole compositions useful as inhibitors of ERK
expired -
US 6528487
Peptide inhibitors of inflammation mediated by selectins
expired -
US 6528508
Inhibitors of p38
expired -
US 6521659
Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor
expired -
US 6518291
Inhibitors of IMPDH enzyme
expired -
US 6517828
C-CAM as an angiogenesis inhibitor
expired -
US 6509363
Heterocyclic inhibitors of p38
expired -
US 6509318
TGF-B inhibitors and methods
expired -
US 6503914
Thienopyrimidine-based inhibitors of the Src family
expired -
US 6500937
Nucleotide sequence encoding a mammary cell growth inhibitor
expired -
US 6498178
Inhibitors of IMPDH enzyme
expired -
US 6495582
Isoxazole compositions useful as inhibitors of ERK
expired -
US 6495591
Fungal efflux pump inhibitors
expired -
US 6489308
Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
expired -
US 6479546
Allosteric inhibitors of lipoxygenase
expired -
US 6476037
L-arginine and phosphodiesterase (PDE) inhibitor synergism
expired